Elevance Health Inc (ELV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,745,900 | 2,490,700 | 3,345,400 | 3,094,900 | 2,463,800 |
| Depreciation Amortization | 553,500 | 571,700 | 586,200 | 604,900 | 556,600 |
| Income taxes - deferred | 61,300 | -481,400 | -105,500 | 273,700 | -102,600 |
| Accounts receivable | -484,200 | -558,700 | -448,600 | -627,800 | -230,400 |
| Accounts payable and accrued liabilities | -748,200 | 194,900 | 257,700 | 852,600 | 46,300 |
| Other Working Capital | 653,800 | -1,513,400 | 494,600 | -41,700 | 123,600 |
| Other Operating Activity | -1,743,200 | 1,831,600 | 214,800 | -112,400 | 278,200 |
| Operating Cash Flow | $3,038,900 | $2,535,400 | $4,344,600 | $4,044,200 | $3,135,500 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 132,400 | 325,100 | 50,600 | 485,200 | -731,400 |
| PPE Investments | -378,000 | -332,900 | -264,700 | -187,500 | -151,600 |
| Net Acquisitions | 4,606,000 | -192,700 | -298,500 | -25,400 | -2,496,900 |
| Purchase Of Investment | -7,554,700 | -7,163,700 | -10,003,600 | -14,015,500 | -21,987,600 |
| Sale Of Investment | 6,229,100 | 7,980,400 | 9,749,501 | 13,310,600 | 20,215,900 |
| Other Investing Activity | -32,000 | 0 | -2,201 | -24,700 | 0 |
| Investing Cash Flow | $3,002,800 | $616,200 | $-768,900 | $-457,300 | $-5,151,600 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -476,500 | -182,300 | -167,700 | -70,900 | 852,600 |
| Debt Issued | 593,300 | -375,600 | 2,481,100 | 2,362,200 | 2,508,200 |
| Debt Repayment | -919,300 | -38,700 | -509,700 | -2,162,100 | -155,100 |
| Common Stock Issued | 126,500 | 121,200 | 784,500 | 559,500 | 429,300 |
| Common Stock Repurchased | -2,638,400 | -3,276,200 | -6,151,400 | -4,550,200 | -333,400 |
| Other Financing Activity | -88,400 | 16,000 | 153,300 | 136,500 | -2,500 |
| Financing Cash Flow | $-3,402,800 | $-3,735,600 | $-3,409,900 | $-3,725,000 | $3,299,100 |
| Exchange Rate Effect | -6,700 | 0 | N/A | N/A | N/A |
| Beginning Cash Position | 2,183,900 | 2,767,900 | 2,602,100 | 2,740,200 | 1,457,200 |
| End Cash Position | 4,816,100 | 2,183,900 | 2,767,900 | 2,602,100 | 2,740,200 |
| Net Cash Flow | $2,632,200 | $-584,000 | $165,800 | $-138,100 | $1,283,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,038,900 | 2,535,400 | 4,344,600 | 4,044,200 | 3,135,500 |
| Capital Expenditure | -378,400 | -345,600 | -322,000 | -193,900 | -161,800 |
| Free Cash Flow | 2,660,500 | 2,189,800 | 4,022,600 | 3,850,300 | 2,973,700 |